SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- Cells for Cells ("C4C"), a clinical-stage biotech pioneering allogeneic stem cell and stem-cells-derived therapeutics for high-impact chronic diseases, ...
c4c endeavours to provide a sustainable, integrated infrastructure for the efficient and swift delivery of high-quality clinical trials in children and young people across all conditions and phases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results